Baxter Pharmaceuticals India Private Limited — Ondansetron Exporter Profile
Indian Pharmaceutical Exporter · #3 for Ondansetron · $10.8M export value · DGFT Verified
Baxter Pharmaceuticals India Private Limited is the #3 Indian exporter of Ondansetron with $10.8M in export value and 272 verified shipments. Baxter Pharmaceuticals India Private Limited holds a 8.9% market share in Ondansetron exports across 19 countries. The company exports 5 pharmaceutical products worth $19.6M across 4 therapeutic categories.
Baxter Pharmaceuticals India Private Limited — Ondansetron Export Profile: Buyers & Destinations
Where Does Baxter Pharmaceuticals India Private Limited Export Ondansetron?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $2.3M | 83 | 34.0% |
| UNITED STATES | $1.2M | 31 | 18.2% |
| COLOMBIA | $1.0M | 26 | 15.3% |
| SOUTH AFRICA | $751.1K | 23 | 11.0% |
| CANADA | $534.6K | 15 | 7.8% |
| KUWAIT | $250.0K | 5 | 3.7% |
| AZARBAIJAN | $97.9K | 4 | 1.4% |
| PHILIPPINES | $97.6K | 4 | 1.4% |
| ISRAEL | $93.7K | 3 | 1.4% |
| AUSTRALIA | $91.8K | 4 | 1.3% |
Baxter Pharmaceuticals India Private Limited exports Ondansetron to 20 countries. The largest destination is BELGIUM accounting for 34.0% of Baxter Pharmaceuticals India Private Limited's Ondansetron shipments, followed by UNITED STATES (18.2%) and COLOMBIA (15.3%). These destinations reflect Baxter Pharmaceuticals India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ondansetron from Baxter Pharmaceuticals India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BAXTER DISTRIBUTION CENTRE EUROPE S | BELGIUM | $2.2M | 80 |
| BAXTER HEALTHCARE CORPORATION | UNITED STATES | $1.0M | 26 |
| LABORATORIOS BAXTER S.A | COLOMBIA | $610.8K | 15 |
| STERIMAX INC | CANADA | $534.6K | 15 |
| PHARMA DYNAMICS | SOUTH AFRICA | $435.4K | 14 |
| LABORATORIOS BAXTER S A | COLOMBIA | $250.0K | 5 |
| BAXTER HEALTHCARE CORPORATION. | UNITED STATES | $236.9K | 5 |
| UPD LEA GLEN | SOUTH AFRICA | $155.0K | 5 |
| ADVANCED TECHNOLOGY COMPANY K.S.C. | KUWAIT | $150.0K | 3 |
| AZERIMED LLC | AZARBAIJAN | $113.0K | 5 |
Baxter Pharmaceuticals India Private Limited supplies Ondansetron to 36 buyers globally. The largest buyer is BAXTER DISTRIBUTION CENTRE EUROPE S (BELGIUM), followed by BAXTER HEALTHCARE CORPORATION (UNITED STATES) and LABORATORIOS BAXTER S.A (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ondansetron Export Value and How Much Does Baxter Pharmaceuticals India Private Limited Contribute?
India exported $100.2M worth of Ondansetron through 8,469 shipments from 537 suppliers to 157 countries, serving 1,636 buyers globally. Baxter Pharmaceuticals India Private Limited contributes $10.8M to this total, accounting for 8.9% of India's Ondansetron exports. Baxter Pharmaceuticals India Private Limited ships Ondansetron to 20 countries through 36 buyers.
What Is the Average Shipment Value for Baxter Pharmaceuticals India Private Limited's Ondansetron Exports?
Baxter Pharmaceuticals India Private Limited's average Ondansetron shipment value is $39.7K per consignment, based on 272 shipments totaling $10.8M. The largest destination is BELGIUM (34.0% of Baxter Pharmaceuticals India Private Limited's Ondansetron exports).
How Does Baxter Pharmaceuticals India Private Limited Compare to Other Indian Ondansetron Exporters?
Baxter Pharmaceuticals India Private Limited ranks #3 among 537 Indian Ondansetron exporters with a 8.9% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($31.2M), GLENMARK PHARMACEUTICALS LIMITED ($15.9M), BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($10.8M). Baxter Pharmaceuticals India Private Limited processed 272 shipments to 19 destination countries.
What Ondansetron Formulations Does Baxter Pharmaceuticals India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ONDANSETRON 2MG/ML SOLUTION FOR INJECTION 2 ML GLASS AMPOULE | $405.2K | 13 |
| ONDANSETRON INJ USP 2 MG/ML 2ML GVNOS | $367.9K | 12 |
| ONDANSETRON 2MG/ML SOLUTION FOR INJECTIO | $320.4K | 11 |
| ONDANSETRON INJECTION BP (8MG/4ML) - 4MLGLASS AMPOULE (BLOKSER) | $311.6K | 7 |
| ONDANSETRON INJ -2MG/ML 2ML GA(EMISTOP) | $290.0K | 9 |
| ONDANSETRON 2 MG/ML SOLUTION FOR INJECTI | $201.6K | 18 |
| ONDANSETRON INJ 2MG/ML 2MLGV USP CA AIN0 | $170.5K | 4 |
| ONDANSETRON 2 MG/ML SOLUTION FOR INJECTION 2 ML GLASS AMPOULE | $166.8K | 5 |
| ONDANSETRON INJ USP 2 MG/ML 2ML GV AIN00 | $150.0K | 3 |
| ONDANSETRON INJ -2MG/ML 2ML GAEMISTOP | $146.3K | 5 |
Baxter Pharmaceuticals India Private Limited exports 128 distinct Ondansetron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ONDANSETRON 2MG/ML SOLUTION FOR INJECTION 2 ML GLASS AMPOULE with 13 shipments worth $405.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Ondansetron to Key Markets
What Baxter Pharmaceuticals India Private Limited must comply with to export Ondansetron to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Baxter Pharmaceuticals India Private Limited Compare to Nearest Ondansetron Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $31.2M | 741 | 14 | $42.2K |
| 2 | GLENMARK PHARMACEUTICALS LIMITED | $15.9M | 635 | 5 | $25.1K |
| 3 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ★ | $10.8M | 272 | 19 | $39.7K |
| 4 | AUROBINDO PHARMA LIMITED | $9.8M | 244 | 6 | $40.1K |
| 6 | DR.REDDY'S LABORATORIES LTD | $5.2M | 213 | 7 | $24.4K |
Baxter Pharmaceuticals India Private Limited ranks #3 among 537 Indian Ondansetron exporters. Average shipment value of $39.7K compared to the market average of $186.5K. The closest competitors by value are AUROBINDO PHARMA LTD and GLENMARK PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Ondansetron Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,058 | 12.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,026 | 12.1% |
| SAHAR AIR | 993 | 11.7% |
| HYDERABAD ICD (INSNF6) | 509 | 6.0% |
| HYDERABAD ICD | 448 | 5.3% |
| JNPT/ NHAVA SHEVA SEA | 343 | 4.1% |
| DELHI AIR CARGO ACC (INDEL4) | 265 | 3.1% |
| AHEMDABAD AIR ACC (INAMD4) | 224 | 2.6% |
What Other Gastrointestinal Products Does Baxter Pharmaceuticals India Private Limited Export?
Baxter Pharmaceuticals India Private Limited also exports these gastrointestinal products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Baxter Pharmaceuticals India Private Limited's Ondansetron Exports
BPIPL's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for Indian exporters. Such challenges necessitate strategic logistics planning to maintain supply chain efficiency.
Conversely, the India-European Union Free Trade Agreement (FTA), signed in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development offers BPIPL enhanced access to European markets, potentially boosting export volumes and revenues. (en.wikipedia.org)
Additionally, the U.S. FDA's warning letter to BPIPL in July 2023 underscores the importance of stringent quality compliance. Addressing such regulatory concerns is crucial for maintaining market access and reputation. (fda.gov)
Baxter Pharmaceuticals India Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for BPIPL. The FDA's 2023 warning letter highlighted significant violations of Current Good Manufacturing Practice (CGMP) regulations at BPIPL's Ahmedabad facility. Proactive measures to rectify these issues are essential to ensure continued market access and uphold the company's reputation. (fda.gov)
Furthermore, the EU's Falsified Medicines Directive mandates rigorous tracking and verification of pharmaceutical products. BPIPL must align its operations with these requirements to capitalize on the opportunities presented by the India-EU FTA.
About Baxter Pharmaceuticals India Private Limited
Baxter Pharmaceuticals India Private Limited exports 5 products worth $19.6M. Beyond Ondansetron, top products include Furosemide, Metoclopramide, Tobramycin, Imipenem. View the complete Baxter Pharmaceuticals India Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ondansetron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ondansetron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Baxter Pharmaceuticals India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 272 individual customs records matching Baxter Pharmaceuticals India Private Limited exporting Ondansetron, covering 128 formulations to 20 countries via 36 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 157+ countries, 1,636+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ondansetron Export Data from Baxter Pharmaceuticals India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Baxter Pharmaceuticals India Private Limited's Ondansetron exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Baxter Pharmaceuticals India Private Limited
Full Company Profile →
5 products · $19.6M total trade · 4 categories
Ondansetron Stats
Company Overview
Top Products by Baxter Pharmaceuticals India Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Baxter Pharmaceuticals India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ondansetron. For current shipment-level data, contact TransData Nexus.